Tetralogy of fallot secondary prevention: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Tetralogy of fallot}} {{CMG}}; {{AE}} {{Fs}} ==Overview== There are no established measures for the secondary prevention of [disease name]. OR Effective measure...")
 
No edit summary
 
Line 4: Line 4:


==Overview==
==Overview==
There are no established measures for the secondary prevention of [disease name].
According to the [[Canadian Cardiovascular Society]]/Canadian Pediatric Cardiology Association, screening for tetralogy of Fallot by pulse oxymetry is recommended for all newborns.
 
OR
 
Effective measures for the secondary prevention of [disease name] include [strategy 1], [strategy 2], and [strategy 3].


==Secondary Prevention==
==Secondary Prevention==
There are no established measures for the secondary prevention of [disease name].
Effective measures for the secondary prevention of tetralogy of fallot include: <ref name="WongFournier2017">{{cite journal|last1=Wong|first1=Kenny K.|last2=Fournier|first2=Anne|last3=Fruitman|first3=Deborah S.|last4=Graves|first4=Lisa|last5=Human|first5=Derek G.|last6=Narvey|first6=Michael|last7=Russell|first7=Jennifer L.|title=Canadian Cardiovascular Society/Canadian Pediatric Cardiology Association Position Statement on Pulse Oximetry Screening in Newborns to Enhance Detection of Critical Congenital Heart Disease|journal=Canadian Journal of Cardiology|volume=33|issue=2|year=2017|pages=199–208|issn=0828282X|doi=10.1016/j.cjca.2016.10.006}}</ref>
 
OR


Effective measures for the secondary prevention of [disease name] include:
*According to the [[Canadian Cardiovascular Society]]/Canadian Pediatric Cardiology Association, screening for tetralogy of Fallot by pulse oxymetry is recommended for all newborns.
*[Strategy 1]
*[Strategy 2]
*[Strategy 3]


==References==
==References==

Latest revision as of 18:19, 14 April 2020

Tetralogy of fallot Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Tetalogy of Fallot from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural history, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Echocardiography

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

ACC/AHA Guidelines for Evaluation and Follow-up


Tetralogy of fallot secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Tetralogy of fallot secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Tetralogy of fallot secondary prevention

CDC on Tetralogy of fallot secondary prevention

Tetralogy of fallot secondary prevention in the news

Blogs on Tetralogy of fallot secondary prevention

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Tetralogy of fallot secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.

Overview

According to the Canadian Cardiovascular Society/Canadian Pediatric Cardiology Association, screening for tetralogy of Fallot by pulse oxymetry is recommended for all newborns.

Secondary Prevention

Effective measures for the secondary prevention of tetralogy of fallot include: [1]

  • According to the Canadian Cardiovascular Society/Canadian Pediatric Cardiology Association, screening for tetralogy of Fallot by pulse oxymetry is recommended for all newborns.

References

  1. Wong, Kenny K.; Fournier, Anne; Fruitman, Deborah S.; Graves, Lisa; Human, Derek G.; Narvey, Michael; Russell, Jennifer L. (2017). "Canadian Cardiovascular Society/Canadian Pediatric Cardiology Association Position Statement on Pulse Oximetry Screening in Newborns to Enhance Detection of Critical Congenital Heart Disease". Canadian Journal of Cardiology. 33 (2): 199–208. doi:10.1016/j.cjca.2016.10.006. ISSN 0828-282X.

Template:WH Template:WS